KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for National Health Investors (NHI) over the last 14 years, with Jun 2025 value amounting to $2.7 billion.

  • National Health Investors' Liabilities and Shareholders Equity rose 8.84% to $2.7 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $7.9 billion, marking a year-over-year increase of 6.50%. This contributed to the annual value of $2.6 billion for FY2024, which is 5.06% up from last year.
  • Per National Health Investors' latest filing, its Liabilities and Shareholders Equity stood at $2.7 billion for Q2 2025, which was down 3.12% from $2.8 billion recorded in Q1 2025.
  • National Health Investors' Liabilities and Shareholders Equity's 5-year high stood at $3.2 billion during Q1 2021, with a 5-year trough of $2.5 billion in Q3 2024.
  • Over the past 3 years, National Health Investors' median Liabilities and Shareholders Equity value was $2.5 billion (recorded in 2023), while the average stood at $2.6 billion.
  • Per our database at Business Quant, National Health Investors' Liabilities and Shareholders Equity dropped by 15.93% in 2022 and then rose by 12.30% in 2025.
  • Over the past 5 years, National Health Investors' Liabilities and Shareholders Equity (Quarterly) stood at $2.9 billion in 2021, then fell by 13.85% to $2.5 billion in 2022, then fell by 0.39% to $2.5 billion in 2023, then dropped by 1.56% to $2.5 billion in 2024, then rose by 8.84% to $2.7 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $2.7 billion for Q2 2025, versus $2.8 billion for Q1 2025 and $2.5 billion for Q3 2024.